Chair & Non-executive Director Research Results 2023


This Research, conducted at our Chair & NED Retreat, provides a fascinating insight into the challenges Boards are facing around the people agenda, financial performance and Board capabilities. 

Key findings from Criticaleye's Chair & NED Research:

  • 23% expect to replace the CEO this year
  • NEDs need to improve knowledge on Technology and ESG
  • Financial performance has moved up the priority list 
  • 87% say the leadership team is too inward looking
  • Leadership capability is the biggest barrier to the talent strategy
  • Less than half (42%) benchmark their strategy outside the organisation
Click here for a recent video where we asked executives what support leaders need from their Boards. Featuring comment from Jan Filakovsky, CEO, Biomapas; Priya Chowdhary, CFO Europe, Encyclis; Beth Henson, Group HRD, ADS Group and Steve Deverill, Managing Partner, Eton Bridge Partners

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 220




Canaccord Genuity Group Inc Worldpay Aldermore Group Lightsource bp NATS LACE Partners Legal & General E.ON UK Drax Group plc Rolls-Royce GlaxoSmithKline plc British Land London Stock Exchange Group AlixPartners Hitachi Solutions NatWest Group